The U.S. government agency has urged AstraZeneca to review the efficacy data and ensure the most accurate, up-to-date data is made public.
AstraZeneca May Have Included ‘Outdated Information’ In U.S. Trial Results, NIAID Says
The U.S. government agency has urged AstraZeneca to review the efficacy data and ensure the most accurate, up-to-date data is made public.